Showing results (141-150 of 654) with videos related to
Sort By:
Pageof 66
The Journal of Allergy and Clinical Immunology|October 1, 1979
Clinical and biochemical effects of impeded androgen (oxymetholone) therapy of hereditary angioedemaA L Sheffer, D T Fearon, K F AustenThe Journal of Experimental Medicine|January 1, 1972
A prealbumin activator of prekallikrein. 3. Appearance of chemotactic activity for human neutrophils by the conversion of human prekallikrein to kallikreinA P Kaplan, A B Kay, K F AustenThe Journal of Clinical Investigation|October 1, 1973
The fibrinolytic pathway of human plasma. II. The generation of chemotactic activity by activation of plasminogen proactivatorA P Kaplan, E J Goetzl, K F AustenThe Journal of Infectious Diseases|May 1, 1975
Studies of immediate hypersensitivity in a patient with Acanthocheilonema perstans filarial infectionR H Rubin, K F Austen, E J GoetzlThe New England Journal of Medicine|March 25, 1976
Cold urticaria: release into the circulation of histamine and eosinophil chemotactic factor of anaphylaxis during cold challengeN A Soter, S I Wasserman, K F AustenJournal of Immunology (Baltimore, Md. : 1950)|March 1, 1982
Antibody restores human alternative complement pathway activation by mouse erythrocytes rendered functionally deficient by pretreatment with pronaseF D Moore, K F Austen, D T FearonProceedings of the National Academy of Sciences of the United States of America|November 1, 1980
Role of adenylate cyclase in immunologic release of mediators from rat mast cells: agonist and antagonist effects of purine- and ribose-modified adenosine analogsS T Holgate, R A Lewis, K F AustenJournal of Immunology (Baltimore, Md. : 1950)|February 1, 1989
Activation- and phorbol ester-stimulated phosphorylation of a plasma membrane glycoprotein antigen expressed on mouse IL-3-dependent mast cells and serosal mast cellsH R Katz, A C Benson, K F AustenThe Journal of Experimental Medicine|April 1, 1971
IgE and IgGa antibody-mediated release of histamine from rat peritoneal cells. I. Optimum conditions for in vitro preparation of target cells with antibody and and challenge with antigenM K Bach, K J Bloch, K F AustenThe Journal of Clinical Investigation|June 1, 1973
Inhibition by C1INH of Hagemann factor fragment activation of coagulation, fibrinolysis, and kinin generationA D Schreiber, A P Kaplan, K F AustenPageof 66